An increase in the content of microRNA-451 in the doxorubicin-resistant breast cancer cell line (MCF-7-DOX) led to a decrease in Pgp expression and, more importantly, to an increase in cellular sensitivity to doxorubicin [86]. The gene discussed is PGP; the disease is breast carcinoma.